米国の在宅輸液療法市場規模、シェア、動向分析レポート：製品別、用途別、セグメント予測、2024年～2030年

米国の在宅輸液療法市場の成長と動向：

Grand View Research社の最新レポートによると、米国の在宅輸液療法市場規模は2030年までに318億米ドルに達する見込みです。

同市場は2024年から2030年にかけてCAGR 7.7％で拡大すると予測されています。高齢者人口の増加と、がん、免疫不全、クローン病、感染症、脱水症、栄養不足、多発性硬化症、吐き気、嘔吐などの疾患の有病率の増加が、市場の成長を大きく促進しています。入院期間の短縮に対するニーズの高まりと、高齢者人口における慢性疾患の有病率の上昇が成長を促進しています。

院内感染（HAI）の増加も、予測期間における米国の在宅輸液療法産業の成長を促進する主な要因です。米国疾病管理予防センターによると、年間約170万人の入院患者がヘルスケア後天性感染症（HCAI）に罹患し、約98,000人（患者の17人に1人）が同感染症が原因で死亡しています。このため、在宅輸液療法の需要は大幅に増加しています。

医療機器や輸液ポンプとともに電子カルテを取り入れるなど、在宅輸液療法における技術革新の増加が動向となっています。電子カルテは医療記録の保存、検索、変更を可能にし、ヘルスケア専門家や患者が特定の疾患の改善を追跡することを容易にします。

入院に比べてコスト効率が良いことから、在宅ヘルスケアを好む患者が増加していることは、業界各社がより革新的な製品を発売する好機となっています。また、安全性の高い製品のイントロダクションは、最終的に米国の在宅輸液療法市場の成長に貢献すると思われます。COVID-19の登場により、バクスター、BD、ICU Medical、Option Care Health, Incのような多くの主要企業が2020年と2021年に在宅輸液製品とサービスの増収を報告し、同国の在宅輸液市場が活性化しました。同国の数多くのヘルスケア施設が、病院やその他の医療施設における患者の入院負担を軽減するために在宅輸液サービスを恒久的に選択することが予想されるため、この動向は市場をさらに押し上げると予想されます。

米国の在宅輸液療法市場レポート・ハイライト

• 輸液ポンプ部門は、必要量の栄養剤、薬剤、その他必要な輸液を供給するために使用され、効率が高まっているため、他と比較して最大の売上シェアを占めています。
• ニードルレスコネクターセグメントは、細菌汚染のリスクが少なく、針刺し損傷に対する保護が高いなど、さまざまな利点があるため、急成長が見込まれています。
• 抗感染剤セグメントは、在宅医療における抗真菌剤、抗生物質、抗ウイルス剤としての広範な使用により、2023年に最大の収益シェアを占めました。
• 内分泌分野は、甲状腺や糖尿病など内分泌系に関連する疾患の増加により、最も急成長する分野と予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の在宅輸液療法市場：セグメント分析、製品別、2018年～2030年

• 製品市場シェア分析、2023年および2030年
• 米国の在宅輸液療法市場、製品別、2023年～2030年
• 2023年から2030年の市場規模、予測、トレンド分析

第4章 米国の在宅輸液療法市場：用途別セグメント分析、2018年～2030年

• 用途市場シェア分析、2023年および2030年
• 米国の在宅輸液療法市場、用途別、2023年～2030年
• 2023年～2030年の市場規模、予測、トレンド分析

第5章 在宅輸液療法市場：国別市場分析、製品別、2018年～2030年

• 市場規模、予測および動向分析、2023年～2030年
• 米国

第6章 在宅輸液療法市場- 競争分析

• Competitive Dashboard Analysis-Impact Analysis
  • 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類（主要なイノベーター、市場リーダー、新興プレーヤー）
  • 主要なイノベーターのリスト
  • マーケットリーダーのリスト
  • 新興選手リスト
• 企業の市況分析（収益、製品ポートフォリオ、主要なサービス可能な産業、主要な提携）
  • 収益別
• Strategy Framework
• 企業プロファイル
  • B. Braun Melsungen AG
  • Baxter
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • JMS Co., Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Coram LLC
  • Option Care Enterprises, Inc.
  • BioScrip, Inc.
  • BriovaRx Infusion Services
  • Paragon Healthcare, Inc.

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Home Infusion Therapy market, leading market players per region
• Table 3 U.S. Home Infusion Therapy market, Regional Network Map
• Table 4 U.S. Home Infusion Therapy market, market differentiating factor

List of Figures

• Fig. 1 U.S. home infusion therapy market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Commodity flow analysis
• Fig. 9 Market outlook (2023)
• Fig. 10 Penetration & growth prospect mapping
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 U.S. population over 60 years by age, 1900 - 2050
• Fig. 13 Prevalence of chronic disease in the U.S.
• Fig. 14 Treatment cost by healthcare setting (Average cost per day in USD)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 PESTLE analysis
• Fig. 18 U.S. Home Infusion Therapy market: Company market share analysis, 2023
• Fig. 19 U.S. Home Infusion Therapy market: Company market share analysis, 2023
• Fig. 20 U.S. Home Infusion Therapy Market: Product movement analysis
• Fig. 21 U.S. Home Infusion Therapy Market Product Outlook: Key takeaways
• Fig. 22 Infusion pumps market, 2018 - 2030 (USD Million)
• Fig. 23 Elastomeric market, 2018 - 2030 (USD Million)
• Fig. 24 Electromechanical market, 2018 - 2030 (USD Million)
• Fig. 25 Gravity market, 2018 - 2030 (USD Million)
• Fig. 26 Others market, 2018 - 2030 (USD Million)
• Fig. 27 Intravenous sets market, 2018 - 2030 (USD Million)
• Fig. 28 Intravenous sets market, 2018 - 2030 (USD Million)
• Fig. 29 Dedicated sets market, 2018 - 2030 (USD Million)
• Fig. 30 IV cannulas market, 2018 - 2030 (USD Million)
• Fig. 31 Needleless connectors market, 2018 - 2030 (USD Million)
• Fig. 32 U.S. home infusion therapy market: Application movement analysis
• Fig. 33 Home infusion therapy market application outlook: Key takeaways
• Fig. 34 Anti-infective market, 2018 - 2030 (USD Million)
• Fig. 35 Endocrinology market, 2018 - 2030 (USD Million)
• Fig. 36 Diabetes market, 2018 - 2030 (USD Million)
• Fig. 37 Others market, 2018 - 2030 (USD Million)
• Fig. 38 Hydration therapy market, 2018 - 2030 (USD Million)
• Fig. 39 Athletes market, 2018 - 2030 (USD Million)
• Fig. 40 Others market, 2018 - 2030 (USD Million)
• Fig. 41 Chemotherapy market, 2018 - 2030 (USD Million)
• Fig. 42 Enteral nutrition market, 2018 - 2030 (USD Million)
• Fig. 43 Parenteral nutrition market, 2018 - 2030 (USD Million)
• Fig. 44 Specialty pharmaceuticals market, 2018 - 2030 (USD Million)
• Fig. 45 Others market, 2018 - 2030 (USD Million)
• Fig. 46 U.S. Country Dynamics
• Fig. 47 Recent Developments & Impact Analysis
• Fig. 48 Strategy Framework

U.S. Home Infusion Therapy Market Growth & Trends:

The U.S. home infusion therapy market size is expected to reach USD 31.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 7.7% from 2024 to 2030. The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market's growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients' preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

U.S. Home Infusion Therapy Market Report Highlights:

• The infusion pumps segment held the largest revenue share compared to others due to the increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids
• The needleless connectors segment is expected to witness the fastest growth owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries
• The anti-infective segment held the maximum revenue share in 2023 owing to its extensive use as an antifungal, antibiotic, and antiviral agent at home care
• Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
• 1.7 List of Secondary Sources
• 1.8 Objectives
  • 1.8.1 Objective 1
  • 1.8.2 Objective 2
  • 1.8.3 Objective 3
  • 1.8.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Penetration & Growth Prospect Mapping
• 2.3 Market Dynamics
  • 2.3.1 Market driver analysis
    • 2.3.1.1 Increasing geriatric population
    • 2.3.1.2 Rising prevalence of chronic disorders
    • 2.3.1.3 Rapid technological advancements
    • 2.3.1.4 Growing incidence of hospital-acquired infections
    • 2.3.1.5 Home healthcare as a cost-effective alternative
  • 2.3.2 Market restrain analysis
    • 2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
  • 2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
  • 2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
• 2.4 U.S. Home Infusion Therapy: Market Analysis Tools
  • 2.4.1 Industry analysis - Porter's
  • 2.4.2 PESTLE analysis
• 2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2023
• 2.6 Major Deals & Strategic Alliances Analysis
• 2.7 Procedure cost analysis/breakdown
• 2.8 Technology Timeline
• 2.9 Regulatory Framework
• 2.10 Reimbursement framework

Chapter 3 U.S Home Infusion Therapy Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 3.1 Product Market Share Analysis, 2023 & 2030
• 3.2 U.S. Home Infusion Therapy Market, by Product, 2023 to 2030
• 3.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
  • 3.3.1 Infusion pumps
    • 3.3.1.1 Infusion Pumps Market, 2018 - 2030 (USD Million)
    • 3.3.1.2 Elastomeric Market, 2018 - 2030 (USD Million)
    • 3.3.1.3 Electromechanical Market, 2018 - 2030 (USD Million)
    • 3.3.1.4 Gravity Market, 2018 - 2030 (USD Million)
    • 3.3.1.5 Others Market, 2018 - 2030 (USD Million)
  • 3.3.2 Intravenous sets
  • 3.3.3 Intravenous Sets Market, 2018 - 2030 (USD Million)
  • 3.3.4 Gravity Sets Market, 2018 - 2030 (USD Million)
  • 3.3.5 Dedicated Sets Market, 2018 - 2030 (USD Million)
  • 3.3.6 IV Cannulas
    • 3.3.6.1 IV Cannulas Market, 2018 - 2030 (Usd Million)
  • 3.3.7 Needleless Connectors
    • 3.3.7.1 Needleless Connectors Market, 2018 - 2030 (USD Million)

Chapter 4 U.S. Home Infusion Therapy Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 4.1 Application Market Share Analysis, 2023 & 2030
• 4.2 U.S. Home Infusion Therapy Market, by Application, 2023 to 2030
• 4.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
  • 4.3.1 Anti-Infective
    • 4.3.1.1 Anti-infective market, 2018 - 2030 (USD Million)
  • 4.3.2 endocrinology
    • 4.3.2.1 ENDOCRINOLOGY MARKET, 2018 - 2030 (USD Million)
    • 4.3.2.2 Diabetes market, 2018 - 2030 (USD Million)
    • 4.3.2.3 Others market, 2018 - 2030 (USD Million)
  • 4.3.3 Hydration therapy
    • 4.3.3.1 hydration therapy market, 2018 - 2030 (USD Million)
    • 4.3.3.2 Athletes market, 2018 - 2030 (USD Million)
    • 4.3.3.3 Others market, 2018 - 2030 (USD Million)
  • 4.3.4 Chemotherapy
    • 4.3.4.1 CHEMOTHERAPY MARKET, 2018 - 2030 (USD Million)
  • 4.3.5 Enteral nutrition
    • 4.3.5.1 ENTERAL NUTRITION market, 2018 - 2030 (USD Million)
  • 4.3.6 Parenteral nutrition
    • 4.3.6.1 PARENTERAL NUTRITION market, 2018 - 2030 (USD Million)
  • 4.3.7 Specialty pharmaceuticals
    • 4.3.7.1 SPECIALTY PHARMACEUTICALS MARKET, 2018 - 2030 (USD Million)
  • 4.3.8 Others
    • 4.3.8.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2018 - 2030 (USD Million)

• 5.1 Market Size, & Forecasts and Trend Analysis, 2023 to 2030
• 5.2 U.S.
  • 5.2.1 U.S. Home Infusion Therapy market, by product, 2018 - 2030 (USD Million)
  • 5.2.2 U.S. Home Infusion Therapy market, by Appliction, 2018 - 2030 (USD Million)

Chapter 6 Home Infusion Therapy Market - Competitive Analysis

• 6.1 Competitive Dashboard Analysis - Impact Analysis
  • 6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
• 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2.1 List of key innovators
  • 6.2.2 List of market leader
  • 6.2.3 List of emerging players
• 6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
  • 6.3.1 By Revenue
• 6.4 Strategy Framework
• 6.5 Company Profiles
  • 6.5.1 B. Braun Melsungen AG
    • 6.5.1.1 Company overview
    • 6.5.1.2 Financial performance
    • 6.5.1.3 Product benchmarking
    • 6.5.1.4 Strategic initiatives
  • 6.5.2 Baxter
    • 6.5.2.1 Company overview
    • 6.5.2.2 Financial performance
    • 6.5.2.3 Product benchmarking
    • 6.5.2.4 Strategic initiatives
  • 6.5.3 Caesarea Medical Electronics
    • 6.5.3.1 Company overview
    • 6.5.3.2 Product benchmarking
    • 6.5.3.3 Strategic initiatives
  • 6.5.4 CareFusion Corporation
    • 6.5.4.1 Company overview
    • 6.5.4.2 Financial performance
    • 6.5.4.3 Product benchmarking
    • 6.5.4.4 Strategic initiatives
  • 6.5.5 Fresenius Kabi AG
    • 6.5.5.1 Company overview
    • 6.5.5.2 Financial performance
    • 6.5.5.3 Product benchmarking
    • 6.5.5.4 Strategic initiatives
  • 6.5.6 ICU Medical, Inc.
    • 6.5.6.1 Company overview
    • 6.5.6.2 Financial performance
    • 6.5.6.3 Product benchmarking
    • 6.5.6.4 Strategic initiatives
  • 6.5.7 JMS Co., Ltd.
    • 6.5.7.1 Company overview
    • 6.5.7.2 Financial performance
    • 6.5.7.3 Product benchmarking
  • 6.5.8 Smiths Medical
    • 6.5.8.1 Company overview
    • 6.5.8.2 Financial performance
    • 6.5.8.3 Product benchmarking
    • 6.5.8.4 Strategic initiatives
  • 6.5.9 Terumo Corporation
    • 6.5.9.1 Company overview
    • 6.5.9.2 Financial performance
    • 6.5.9.3 Product benchmarking
    • 6.5.9.4 Strategic initiatives
  • 6.5.10 Coram LLC
    • 6.5.10.1 Company overview
    • 6.5.10.2 Product benchmarking
  • 6.5.11 Option Care Enterprises, Inc.
    • 6.5.11.1 Company overview
    • 6.5.11.2 Financial performance
    • 6.5.11.3 Product benchmarking
    • 6.5.11.4 Strategic initiatives
  • 6.5.12 BioScrip, Inc.
    • 6.5.12.1 Company overview
    • 6.5.12.2 Financial performance
    • 6.5.12.3 Product benchmarking
    • 6.5.12.4 Strategic initiatives
  • 6.5.13 BriovaRx Infusion Services
    • 6.5.13.1 Company overview
    • 6.5.13.2 Financial performance
    • 6.5.13.3 Product benchmarking
    • 6.5.13.4 Strategic initiatives
  • 6.6.14 Paragon Healthcare, Inc.
    • 6.6.14.1 Company overview
    • 6.6.14.2 Financial performance
    • 6.6.14.3 Product benchmarking